- call +1-201-465-4211
- email sales@mrinsights.biz
Scope of the Report:
The global Rapid Influenza Diagnostic Test (RIDT) market is valued at 1001.3 million USD in 2018 and is expected to reach 1377.3 million USD by the end of 2024, growing at a CAGR of 8.3% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Rapid Influenza Diagnostic Test (RIDT).
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Rapid Influenza Diagnostic Test (RIDT) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Rapid Influenza Diagnostic Test (RIDT) market by product type and applications/end industries.
Market Segment by Companies, this report covers
Analytik Jena
Princeton BioMeditech Corporation
Roche
Abbot (Alere)
BD
Quidel
Sekisui Diagnostics
Meridian Bioscience
Thermo Fisher Scientific
BioMerieux
Response Biomedical
SA Scientific
DiaSorin (Focus Diagnostics)
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Digital RIDTs
Conventional RIDT
In 2018, Digital RIDTs accounted for a major share of 55.36% the global Rapid Influenza Diagnostic Test (RIDT) market. And this product segment is poised to reach 1039.09 million US$ by 2025 from 588.84 million US$ in 2018.
Market Segment by Applications, can be divided into
Hospitals
POCT
Others
In Rapid Influenza Diagnostic Test (RIDT) market, the Hospitals holds an important share in terms of application, and it is expected to reach revenue of by 2025, at a CAGR of 8.37% during 2019 and 2025.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Rapid Influenza Diagnostic Test (RIDT) Market Overview
1.1 Product Overview and Scope of Rapid Influenza Diagnostic Test (RIDT)
1.2 Classification of Rapid Influenza Diagnostic Test (RIDT) by Types
1.2.1 Global Rapid Influenza Diagnostic Test (RIDT) Revenue Comparison by Types (2019-2024)
1.2.2 Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Types in 2018
1.2.3 Digital RIDTs
1.2.4 Conventional RIDT
1.3 Global Rapid Influenza Diagnostic Test (RIDT) Market by Application
1.3.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 POCT
1.3.4 Others
1.4 Global Rapid Influenza Diagnostic Test (RIDT) Market by Regions
1.4.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Rapid Influenza Diagnostic Test (RIDT) Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Rapid Influenza Diagnostic Test (RIDT) Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rapid Influenza Diagnostic Test (RIDT) Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Rapid Influenza Diagnostic Test (RIDT) Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rapid Influenza Diagnostic Test (RIDT) Status and Prospect (2014-2024)
1.5 Global Market Size of Rapid Influenza Diagnostic Test (RIDT) (2014-2024)
2 Company Profiles
2.1 Analytik Jena
2.1.1 Business Overview
2.1.2 Rapid Influenza Diagnostic Test (RIDT) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Revenue, Gross Margin and Market Share (2017-2018)
2.2 Princeton BioMeditech Corporation
2.2.1 Business Overview
2.2.2 Rapid Influenza Diagnostic Test (RIDT) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Revenue, Gross Margin and Market Share (2017-2018)
2.3 Roche
2.3.1 Business Overview
2.3.2 Rapid Influenza Diagnostic Test (RIDT) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Roche Rapid Influenza Diagnostic Test (RIDT) Revenue, Gross Margin and Market Share (2017-2018)
2.4 Abbot (Alere)
2.4.1 Business Overview
2.4.2 Rapid Influenza Diagnostic Test (RIDT) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Revenue, Gross Margin and Market Share (2017-2018)
2.5 BD
2.5.1 Business Overview
2.5.2 Rapid Influenza Diagnostic Test (RIDT) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 BD Rapid Influenza Diagnostic Test (RIDT) Revenue, Gross Margin and Market Share (2017-2018)
2.6 Quidel
2.6.1 Business Overview
2.6.2 Rapid Influenza Diagnostic Test (RIDT) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Quidel Rapid Influenza Diagnostic Test (RIDT) Revenue, Gross Margin and Market Share (2017-2018)
2.7 Sekisui Diagnostics
2.7.1 Business Overview
2.7.2 Rapid Influenza Diagnostic Test (RIDT) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Revenue, Gross Margin and Market Share (2017-2018)
2.8 Meridian Bioscience
2.8.1 Business Overview
2.8.2 Rapid Influenza Diagnostic Test (RIDT) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Revenue, Gross Margin and Market Share (2017-2018)
2.9 Thermo Fisher Scientific
2.9.1 Business Overview
2.9.2 Rapid Influenza Diagnostic Test (RIDT) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue, Gross Margin and Market Share (2017-2018)
2.10 BioMerieux
2.10.1 Business Overview
2.10.2 Rapid Influenza Diagnostic Test (RIDT) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 BioMerieux Rapid Influenza Diagnostic Test (RIDT) Revenue, Gross Margin and Market Share (2017-2018)
2.11 Response Biomedical
2.11.1 Business Overview
2.11.2 Rapid Influenza Diagnostic Test (RIDT) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Revenue, Gross Margin and Market Share (2017-2018)
2.12 SA Scientific
2.12.1 Business Overview
2.12.2 Rapid Influenza Diagnostic Test (RIDT) Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 SA Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue, Gross Margin and Market Share (2017-2018)
2.13 DiaSorin (Focus Diagnostics)
2.13.1 Business Overview
2.13.2 Rapid Influenza Diagnostic Test (RIDT) Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Revenue, Gross Margin and Market Share (2017-2018)
3 Global Rapid Influenza Diagnostic Test (RIDT) Market Competition, by Players
3.1 Global Rapid Influenza Diagnostic Test (RIDT) Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Rapid Influenza Diagnostic Test (RIDT) Players Market Share
3.2.2 Top 10 Rapid Influenza Diagnostic Test (RIDT) Players Market Share
3.3 Market Competition Trend
4 Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Regions
4.1 Global Rapid Influenza Diagnostic Test (RIDT) Revenue and Market Share by Regions
4.2 North America Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
4.3 Europe Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
4.5 South America Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
5 North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Countries
5.1 North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Countries (2014-2019)
5.2 USA Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
5.3 Canada Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
5.4 Mexico Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
6 Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Countries
6.1 Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Countries (2014-2019)
6.2 Germany Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
6.3 UK Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
6.4 France Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
6.5 Russia Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
6.6 Italy Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Revenue by Countries
7.1 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Revenue by Countries (2014-2019)
7.2 China Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
7.3 Japan Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
7.4 Korea Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
7.5 India Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
8 South America Rapid Influenza Diagnostic Test (RIDT) Revenue by Countries
8.1 South America Rapid Influenza Diagnostic Test (RIDT) Revenue by Countries (2014-2019)
8.2 Brazil Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
8.3 Argentina Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
8.4 Colombia Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Rapid Influenza Diagnostic Test (RIDT) by Countries
9.1 Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Revenue by Countries (2014-2019)
9.2 Saudi Arabia Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
9.3 UAE Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
9.4 Egypt Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
9.5 Nigeria Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
9.6 South Africa Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2014-2019)
10 Global Rapid Influenza Diagnostic Test (RIDT) Market Segment by Type
10.1 Global Rapid Influenza Diagnostic Test (RIDT) Revenue and Market Share by Type (2014-2019)
10.2 Global Rapid Influenza Diagnostic Test (RIDT) Market Forecast by Type (2019-2024)
10.3 Digital RIDTs Revenue Growth Rate (2014-2024)
10.4 Conventional RIDT Revenue Growth Rate (2014-2024)
11 Global Rapid Influenza Diagnostic Test (RIDT) Market Segment by Application
11.1 Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Application (2014-2019)
11.2 Rapid Influenza Diagnostic Test (RIDT) Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 POCT Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Rapid Influenza Diagnostic Test (RIDT) Market Size Forecast (2019-2024)
12.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Size Forecast (2019-2024)
12.2 Global Rapid Influenza Diagnostic Test (RIDT) Market Forecast by Regions (2019-2024)
12.3 North America Rapid Influenza Diagnostic Test (RIDT) Revenue Market Forecast (2019-2024)
12.4 Europe Rapid Influenza Diagnostic Test (RIDT) Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Revenue Market Forecast (2019-2024)
12.6 South America Rapid Influenza Diagnostic Test (RIDT) Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Rapid Influenza Diagnostic Test (RIDT) Picture
Table Product Specifications of Rapid Influenza Diagnostic Test (RIDT)
Table Global Rapid Influenza Diagnostic Test (R
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
